Talia Flanagan - Publications, H-index & Citations

Talia Flanagan

AstraZeneca

23H指数

60论文数

2.0K被引数

收录论文 33

发表时间

The Patient-Centric Formulation Compass: A Proposed Bottom-Up Framework to Translate Population Insights into Product Design 以患者为中心的配方指南：一种将人群见解转化为产品设计并自下而上的框架

AAPS Journal

IF3.7

2026-10-15

PREAI

Domagoj Segregur; Pascal Somville; Jérôme Mantanus; Talia Flanagan

Characterization of Aspirated Duodenal Fluids from Parkinson's Disease Patients

PHARMACEUTICS

IF5.5

2023-04-14

OAAI

de Waal, Tom; Brouwers, Joachim; Berben, Philippe; Flanagan, Talia; Tack, Jan; Vandenberghe, Wim; Vanuytsel, Tim; Augustijns, Patrick

Chemistry Manufacturing and Controls Development, Industry Reflections on Manufacture, and Supply of Pandemic Therapies and Vaccines

AAPS JOURNAL

IF3.7

2022-09-27

OAAI

Popkin, Matthew E.; Goese, Markus; Wilkinson, Diane; Finnie, Stuart; Flanagan, Talia; Campa, Cristiana; Clinch, Alexandra; Teasdale, Andrew; Lennard, Andrew; Cook, Graham; Mohan, Ganapathy; Osborne, Matthew D.

Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series

PHARMACEUTICS

IF5.5

2022-05-07

OAAI

McAllister, Mark; Flanagan, Talia; Cole, Susan; Abend, Andreas; Kotzagiorgis, Evangelos; Limberg, Jobst; Mead, Heather; Mangas-Sanjuan, Victor; Dickinson, Paul A.; Moir, Andrea; Pepin, Xavier; Zhou, Diansong; Tistaert, Christophe; Dokoumetzidis, Aristides; Anand, Om; Le Merdy, Maxime; Turner, David B.; Griffin, Brendan T.; Darwich, Adam; Dressman, Jennifer; Mackie, Claire

A Critical Overview of the Biological Effects of Excipients (Part I): Impact on Gastrointestinal Absorption

AAPS JOURNAL

IF3.7

2022-05-02

PREAI

Martinez, Marilyn N.; Sinko, Balint; Wu, Fang; Flanagan, Talia; Borbas, Eniko; Tsakalozou, Eleftheria; Giacomini, Kathleen M.

Applications of Physiologically Based Biopharmaceutics Modeling (PBBM) to Support Drug Product Quality: A Workshop Summary Report 基于生理的生物药剂学建模 (PBBM) 在支持药品质量中的应用: 研讨会总结报告

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2021-02-01

OAAI

Mitra, Amitava; Suarez-Sharp, Sandra; Pepin, Xavier J. H.; Flanagan, Talia; Zhao, Yang; Kotzagiorgis, Evangelos; Parrott, Neil; Sharan, Satish; Tistaert, Christophe; Heimbach, Tycho; Zolnik, Banu; Sjogren, Erik; Wu, Fang; Anand, Om; Kakar, Shefali; Li, Min; Veerasingham, Shereeni; Kijima, Shinichi; Lima Santos, Gustavo Mendes; Ning, Baoming; Raines, Kimberly; Rullo, Greg; Mandula, Haritha; Delvadia, Poonam; Dressman, Jennifer; Dickinson, Paul A.; Babiskin, Andrew

Best Practices in the Development and Validation of Physiologically Based Biopharmaceutics Modeling. A Workshop Summary Report

JOURNAL OF PHARMACEUTICAL SCIENCES

IF3.8

2021-02-01

OAAI

Parrott, Neil; Suarez-Sharp, Sandra; Kesisoglou, Filippos; Pathak, Shriram M.; Good, David; Wagner, Christian; Dallmann, Andre; Mullin, James; Patel, Nikunjkumar; Riedmaier, Arian Emami; Mitra, Amitava; Raines, Kimberly; Butler, James; Kakhi, Maziar; Li, Min; Zhao, Yang; Tsakalozou, Eleftheria; Flanagan, Talia; Dressman, Jennifer; Pepin, Xavier

Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products (vol 22, 97, 2020)

AAPS JOURNAL

IF3.7

2020-12-03

OAAI

Selen, Arzu; Mullertz, Anette; Kesisoglou, Filippos; Ho, Rodney J. Y.; Cook, Jack A.; Dickinson, Paul A.; Flanagan, Talia

BCS-based biowaivers: Extension to paediatrics

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2020-12-01

OAAI

Martir, J.; Flanagan, T.; Mann, J.; Fotaki, N.

Impact of Food and Drink Administration Vehicles on Paediatric Formulation Performance Part 2: Dissolution of Montelukast Sodium and Mesalazine Formulations

AAPS PHARMSCITECH

IF4

2020-10-15

OAAI

Martir, J.; Flanagan, T.; Mann, J.; Fotaki, Nikoletta

In VivoPredictive Dissolution Testing of Montelukast Sodium Formulations Administered with Drinks and Soft Foods to Infants

AAPS PHARMSCITECH

IF4

2020-10-13

OAAI

Martir, J.; Flanagan, T.; Mann, J.; Fotaki, N.

Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products

AAPS JOURNAL

IF3.7

2020-07-27

PREAI

Selen, Arzu; Mullertz, Anette; Kesisoglou, Filippos; Ho, Rodney J. Y.; Cook, Jack A.; Dickinson, Paul A.; Flanagan, Talia

Impact of Food and Drink Administration Vehicles on Paediatric Formulation Performance: Part 1-Effects on Solubility of Poorly Soluble Drugs

AAPS PHARMSCITECH

IF4

2020-06-26

OAAI

Martir, J.; Flanagan, T.; Mann, J.; Fotaki, N.

Impact of Magnesium Stearate Presence and Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties

AAPS JOURNAL

IF3.7

2020-05-21

OAAI

Zarmpi, P.; Flanagan, T.; Meehan, E.; Mann, J.; Fotaki, Nikoletta

Impact of gastrointestinal physiology on drug absorption in special populations??An UNGAP review

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2020-04-01

165

OAAI

Stillhart, Cordula; Vucicevic, Katarina; Augustijns, Patrick; Basit, Abdul W.; Batchelor, Hannah; Flanagan, Talia R.; Gesquiere, Ina; Greupink, Rick; Keszthelyi, Daniel; Koskinen, Mikko; Madla, Christine M.; Matthys, Christophe; Miljus, Goran; Mooij, Miriam G.; Parrott, Neil; Ungell, Anna -Lena; de Wildt, Saskia N.; Orlu, Mine; Klein, Sandra; Mullertz, Anette

Co-administration of Paediatric Medicines with Food and Drinks in the Context of Their Physicochemical Properties-a Global Perspective on Practices and Recommendations

AAPS JOURNAL

IF3.7

2020-03-04

OAAI

Martir, Joana; Flanagan, Talia; Mann, James; Fotaki, Nikoletta

Surface dissolution UV imaging for characterization of superdisintegrants and their impact on drug dissolution

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2020-03-01

OAAI

Zarmpi, P.; Flanagan, T.; Meehan, E.; Mann, J.; Fotaki, N.

Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties: Case Study-Hypromellose (HPMC)

AAPS JOURNAL

IF3.7

2020-02-18

OAAI

Zarmpi, P.; Flanagan, T.; Meehan, E.; Mann, J.; Fotaki, N.

Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties. Case Study: Superdisintegrants

AAPS JOURNAL

IF3.7

2020-02-11

OAAI

Zarmpi, Panagiota; Flanagan, Talia; Meehan, Elizabeth; Mann, James; Fotaki, Nikoletta

Developing Clinically Relevant Dissolution Specifications for Oral Drug Products-Industrial and Regulatory Perspectives 制定口服药物产品的临床相关溶出度规范-工业和监管观点

PHARMACEUTICS

IF5.5

2019-12-23

OAAI

McAllister, Mark; Flanagan, Talia; Boon, Karin; Pepin, Xavier; Tistaert, Christophe; Jamei, Masoud; Abend, Andreas; Kotzagiorgis, Evangelos; Mackie, Claire

研究方向